Page 16 - Libro Memoria Cien Inglés

From this moment on, the requests for 2020 due to the COVID-19 pandemic
reports will be processed to the corres-
ponding committee.
With regard to the functions des-
cribed in Law 14/2007 on Biomedical
Research, the Committee provides
services to the Centers and Units of
the Carlos III Institute of Health, to the
Foundations promoted by it and to
mixed or associated Centers recogni-
zed by the Carlos III Institute of Health.
Thus, the CIEN Foundation requests
a report on any study carried out with
human beings, their samples, or their
data through the Research Ethics
Committee (CEI, for its acronym in
Spanish).
1.4. Future outlook
In 2021, and in subsequent years,
the CIEN Foundation will continue
to promote the research work that
has placed it as a reference in Spain
in research on Alzheimer's and other
dementias.
In addition, it will continue to promote
its participation in research programs.
The CIEN Foundation will carry on
during 2021 with the management of
CIBERNED (initials in Spanish for Cen-
ter for Biomedical Research on Neu-
rodegenerative Diseases Network). In
this context of strengthening the CIEN
Foundation-CIBERNED relationship,
both institutions have postponed in
Cien Foundation annual report 2020
the Global Summit Neuro 2020, an
event under the honorary presidency
of Her Majesty Queen Sofia, which fna-
lly will be held in Salamanca in 2022,
also coinciding with the VIII edition
of the International Congress on Re-
search and Innovation in Neurodege-
nerative Diseases, and the XV CIBER-
NED Scientific Forum.
During 2021 the launch of a new plat-
form based on new ultrasensitive tech-
nologies for the detection of biomar-
kers in biological fluids useful in the
early diagnosis of neurodegenerative
diseases is expected. The acquisition of
new equipment with this technology
based on digital ELISA for single mo-
lecule detection will allow the establi-
shment of the necessary procedures
for its implementation during the first
months of the year. In the context of
the CIEN Foundation, the acquisition of
a highly sensitive peripheral biomarker
analysis platform is considered espe-
cially relevant for the enhancement
and better use of the Vallecas Project,
as well as other Foundation projects.
In addition to continuing the studies
launched, there are several new lines
of research around the Vallecas pro-
ject that are considered to be of great
interest in the near future. Likewise,
the results of different ongoing studies
(explained in detail in Section 4 of this
report devoted to the Vallecas Project)
are expected to be published in 2021.
16